Literature DB >> 18948436

Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.

William B Grant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18948436      PMCID： PMC2570147          DOI： 10.2353/ajpath.2008.080579

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  13 in total

1.  Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.

Authors:  John N Flanagan; Michael V Young; Kelly S Persons; Lilin Wang; Jeffrey S Mathieu; Lyman W Whitlatch; Michael F Holick; Tai C Chen
Journal:  Anticancer Res       Date:  2006 Jul-Aug       Impact factor: 2.480

2.  Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

Authors:  G G Schwartz; B S Hulka
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

3.  Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.

Authors:  Tomasz M Beer; Christopher W Ryan; Peter M Venner; Daniel P Petrylak; Gurkamal S Chatta; J Dean Ruether; Charles H Redfern; Louis Fehrenbacher; Mansoor N Saleh; David M Waterhouse; Michael A Carducci; Daniel Vicario; Robert Dreicer; Celestia S Higano; Frederick R Ahmann; Kim N Chi; W David Henner; Alan Arroyo; Fong W Clow
Journal:  J Clin Oncol       Date:  2007-02-20       Impact factor: 44.544

4.  Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.

Authors:  Jenny Kaeding; Julie Bélanger; Patrick Caron; Mélanie Verreault; Alain Bélanger; Olivier Barbier
Journal:  Mol Cancer Ther       Date:  2008-02       Impact factor: 6.261

Review 5.  Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity.

Authors:  Aruna V Krishnan; Jacqueline Moreno; Larisa Nonn; Srilatha Swami; Donna M Peehl; David Feldman
Journal:  J Bone Miner Res       Date:  2007-12       Impact factor: 6.741

6.  1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis.

Authors:  Gladson Muthian; Himanshu P Raikwar; Johnson Rajasingh; John J Bright
Journal:  J Neurosci Res       Date:  2006-05-15       Impact factor: 4.164

7.  Nucleocytoplasmic shuttling of persistently activated STAT3.

Authors:  Andreas Herrmann; Michael Vogt; Martin Mönnigmann; Thomas Clahsen; Ulrike Sommer; Serge Haan; Valeria Poli; Peter C Heinrich; Gerhard Müller-Newen
Journal:  J Cell Sci       Date:  2007-08-28       Impact factor: 5.285

8.  Serum vitamin D concentration and prostate cancer risk: a nested case-control study.

Authors:  Jiyoung Ahn; Ulrike Peters; Demetrius Albanes; Mark P Purdue; Christian C Abnet; Nilanjan Chatterjee; Ronald L Horst; Bruce W Hollis; Wen-Yi Huang; James M Shikany; Richard B Hayes
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

9.  Prostate cancer survival is dependent on season of diagnosis.

Authors:  Zoya Lagunova; Alina Carmen Porojnicu; Arne Dahlback; Jens Petter Berg; Tomasz M Beer; Johan Moan
Journal:  Prostate       Date:  2007-09-01       Impact factor: 4.104

10.  Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

Authors:  Francis P Boscoe; Maria J Schymura
Journal:  BMC Cancer       Date:  2006-11-10       Impact factor: 4.430
View more
  5 in total

Review 1.  The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃.

Authors:  E Vanoirbeek; A Krishnan; G Eelen; L Verlinden; R Bouillon; D Feldman; A Verstuyf
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-08       Impact factor: 4.690

2.  An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption and urban/rural residence.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2010-04

3.  The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer.

Authors:  Rong Lu; Shaoping Wu; Yinglin Xia; Jun Sun
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03-01

4.  How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

Review 5.  Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Francesca Sperati; Patrizia Vici; Marcello Maugeri-Saccà; Saverio Stranges; Nancy Santesso; Luciano Mariani; Antonio Giordano; Domenico Sergi; Laura Pizzuti; Luigi Di Lauro; Maurizio Montella; Anna Crispo; Marcella Mottolese; Maddalena Barba
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.